Eculizumab Biosimilar Appears Effective in Paroxysmal Nocturnal Hemoglobinuria
Researchers sought to determine whether SB12 would be a clinical equivalent to eculizumab for improving lactate dehydrogenase levels in patients with PNH.
Researchers sought to determine whether SB12 would be a clinical equivalent to eculizumab for improving lactate dehydrogenase levels in patients with PNH.
Changes in anemia care associated with lower risks for major adverse cardiovascular events, stroke, mortality, heart failure.
Researchers sought to determine whether canakinumab would reduce daily sickle cell anemia-related pain in patients with SCA.
Researchers sought to describe the diagnosis and treatment of patients with rare cases of PNH.
Researchers sought to determine whether fertility-related education would be needed for adolescents and young adults with SCD.
Researchers sought to determine whether an intervention package would improve clinical guidance adherence and hemoglobin levels among pregnant patients with anemia.
Researchers sought to evaluate the rates of anemia in women of reproductive age in 15 low- to middle-income countries.
Researchers sought to evaluate the effect of the CDC’s guideline on opioid prescriptions and health outcomes on patients with SCD.
Researchers sought to determine whether there is a link between non-coding genetic variants of PKLR and acute pain in sickle cell disease.
Researchers sought to determine whether thromboprophylaxis would reduce venous thromboembolism risk in patients with SCD and a central venous access device.